OMS Pharmacy, Inc. v. Nationwide Property & Casualty Insurance Co., No. SC-2025-0165, 2026 WL 3031566 (Ala. Oct. 9, 2026). The Court (Stewart, C.J.; Wise, Bryan, Sellers, Mendheim, Cook, and McCool, JJ., concur; Parker, J., concurs in part and concurs in the result, with opinion; Shaw, J., recuses) affirms summary judgments for Nationwide and the insurance agencies. Id. at *13. Browne obtained a $4.75 million consent judgment against OMS after a compounding error caused her to consume medication containing belladonna one thousand times stronger than prescribed. Id. at *1, *3. The Court holds that compounding prescription medication constitutes a professional pharmacy service within the policy’s express professional-services exclusion. Id. at **6–7. The exclusion encompasses Browne’s products-liability claims because its unambiguous “arises out of” language applies regardless of the theory of recovery, and every claim originated in the compounding error. Id. at *7. The Court also holds that OMS’s failure to read the policy’s clear exclusion establishes contributory negligence as a matter of law, defeating its claim that the agencies negligently failed to procure coverage equivalent to its former policy. Id. at *8, *12. The Court rejects the wanton-procurement claim because OMS presented no substantial evidence that the agencies consciously acted or omitted a duty knowing injury would likely result. Id. at *12. Justice Parker emphasizes that wantonness turns on actual awareness of likely injury, not malicious intent. Id. at *13.